Abstract:In the present work, we successfully synthesized Se -alkyl selenopyridines 1 and 3 , selenopheno[2,3- b ]pyridine 2 , and bis-selenopyridine 4 derivatives using an eco-friendly method by utilizing NaHSe instead of toxic hydrogen selenide. The effect of the temperature on the reaction was screening at various temperatures. The regiospecific reaction of selenopyridine 1 with bromine afforded an unexpected product 4,6-diamino-5-bromo-2-[(cyanomethyl)selenyl]-pyridine-3-carbonitrile ( 5 ), which was cyclized to selenopheno[2,3- b ]pyridine ( 7 ) by refluxing in the presence of TEA. While its treatment with thiophenol and/or p -chlorothiophenol gave 8a , b . On the other hand, its reaction with aminothiophenol afforded 2-(benzo[ d ]-thiazol-2-yl)-5-bromoselenopheno[2,3- b ]pyridine-3,4,6-triamine ( 9 ). Also, N -(2-cyano-4-methyl-5 H -1-seleno-3,5,8-triazaacenaphthylen-7-yl)acetamide ( 11 ) and a novel series of selenoazo dyes 12a – d were synthesized by treatment of selenopheno[2,3- b ]pyridine 2 with acetic anhydride and/or diazonium chlorides of aromatic amines, respectively. Then, we ascertained the potential activity of synthesized compounds against highly metastatic prostate cancer cells (PC-3) and osteosarcoma cells (MG-63) and found that 12a , 12b , 12c , and 12d were more cytotoxic than doxorubicin in both tested cell lines, showing nearly the same anticancer activity with IC 50 values ranging from 2.59 ± 0.02 μM to 3.93 ± 0.23 μM. Mechanistically, the most potent compounds 12a and 12b proved to be potent EGFR inhibitors with IC 50 values of 0.301 and 0.123 μM, respectively, compared to lapatinib as a positive reference (IC 50 = 0.049 μM). Moreover, the docking results are in good agreement with the anticancer activity as well as the EGFR inhibitory activity, suggesting these two compounds as promising EGFR anticancer candidates.

Synthesis and Potential Anticancer Activity of Some Novel Selenocyanates and Diselenides

New Organoselenides (Nsaids-Se Derivatives) As Potential Anticancer Agents: Synthesis, Biological Evaluation and in Silico Calculations.

New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations

Synthesis and Biological Evaluation of Organoselenium (Nsaids-Secn and SeCF3) Derivatives As Potential Anticancer Agents.

Synthesis of NSAIDs–Se Derivatives As Potent Anticancer Agents

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Recent Advances for the Synthesis of Selenium-containing Small Molecules As Potent Antitumor Agents.

Design, Synthesis, and Biological Evaluations of Novel Naphthalene-based Organoselenocyanates

Synthesis of New Chiral β-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation—Part I

Synthesis of selenophene‐containing flavonols and 2‐styrylchromones: Evaluation of their activities compared with selenophene‐containing chalcones as potential anticancer agents

Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas

Synthesis and anticancer evaluation of new disulfides incorporating naphthalimide moiety

Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance

Synthesis of novel supramolecular selenomolybdate as anticancer agents: An experimental and DFT computational analysis

An efficient methodological approach for synthesis of selenopyridines: generation, reactions, anticancer activity, EGFR inhibitory activity and molecular docking studies

Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations

Anticancer Activity of Biogenically Synthesized Selenium Nanoparticles Using Catharanthus Roseus

Facile synthesis and anti-tumor cell activity of Se-containing nucleosides.

Discovery, Synthesis, and Activity Evaluation of Novel Five-Membered Sulfur-Containing Heterocyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo

Inhibition of Thioredoxin Reductase by a Novel Series of Bis-1,2-benzisoselenazol-3(2h)-ones: Organoselenium Compounds for Cancer Therapy.

Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production